Archive for February, 2010

« Previous Entries

Thyroid Hormone Boosts In Vitro Success, Researchers Find

Wednesday, February 24th, 2010

Adding thyroid hormone to the in vitro fertilization process produces more viable embryos and has the potential to increase the success rates of pregnancy, according to a groundbreaking study by University of Guelphresearchers. A team of biomedical scientists discovered that adding the synthetic hormone to bovine eggs after fertilization boosted the number of viable embryos by 30 per […]

Menopause linked to increased risk for gout

Tuesday, February 23rd, 2010

Source: MedWire News Study findings suggest that menopause is linked to an increased risk for gout, which is reduced through postmenopausal hormone therapy. The researchers used data from the Nurses’ Health Study to examine the association between menopause, age at menopause, postmenopausal hormone use, and risk for self-reported physician diagnosed incident gout among 92,535 women […]

Statins May Significantly Reduce Prostate Tumor Inflammation.

Tuesday, February 23rd, 2010

HealthDay (2/22, Preidt) reported that “cholesterol-lowering statins significantly reduce prostate tumor inflammation, which may help lower the risk of disease progression,” according to a study published online in the journal Cancer Epidemiology, Biomarkers & Prevention. Investigators “examined tissue samples of prostate tumors from 236 men undergoing prostate cancer surgery.” The researchers “concluded that statin use […]

Phisohex Still Available in Canada

Sunday, February 21st, 2010

With Phisohex taken off the market in the United States, many Americans are trying to find Phisohex soap.  Phisohex is still available in Canada.  Universal Drugstore is at the forefront of providing Phisohex cleanser.   Phisohex uses are many.  Go here to find Phisohex prices.

Big pharma companies look to tap generic drug business in emerging markets.

Friday, February 19th, 2010

On the front of its Business Day section, the New York Times (2/16, B1, Singer) reports, “Some prestigious brand-name pharmaceutical companies that once looked askance at the high-volume, low-cost business of generic drugs are now becoming major purveyors of generic medicines.” Drugmakers, such as Sanofi-Aventis and GlaxoSmithKline “are pursuing a growing consumer base in emerging […]

Raltegravir, efavirenz may offer comparable outcomes in patients with HIV.

Friday, February 19th, 2010

MedPage Today (2/18, Susman) reported “that patients infected with human immunodeficiency virus and treated with the integrase inhibitor raltegravir (Isentress) fare as well as patients treated with efavirenz (Sustiva).” Although “the side effects on lipids favor raltegravir,” Peruvian scientists explained that “74% of patients treated with a raltegravir-based regimen and 74% of patients treated with […]

Gilead Quad AIDS Pill Safer, Better Than Atripla

Thursday, February 18th, 2010

Gilead Sciences Inc.’s four-in-one combination pill for AIDS had fewer side effects and may be more effective than its three-drug treatment Atripla, the world’s best-selling HIV therapy, a study found. The quad pill reduced the virus to undetectable levels in 90 percent of patients after 24 weeks, compared with 83 percent on Atripla, according to […]

Government halting production of natural thyroid drugs.

Thursday, February 18th, 2010

Source: amouthfulofhealth.blogspot.com Government halting production of natural thyroid drugs. Recently, Major Pharmaceuticals issued a press release stating that the US Food and Drug Administration (FDA) has requiredthem to cease production of a century old treatment option, a naturally dessicated thyroid drug , due to a change in FDA regulatory procedures. Under their “Unapproved Drugs Campaign”, the FDA is eliminating the regulations that previously allowed […]

FDA Attacks Natural Thyroid Millions Depend On

Thursday, February 18th, 2010

Source: PortaltoHealing.com We have learned that Time-Cap Labs, producer of a generic version of the brand name drug Armour, a natural and bioidentical thyroid replacement, has been ordered by the FDA to stop production. The FDA has decided to classify the company’s product, available for over a century, as an unapproved new drug.  Since the […]

Factors predicting erectile dysfunction in men with Type 2 diabetes clarified

Thursday, February 18th, 2010

Source: MedWire News Poor glycemic control, presence of the metabolic syndrome, and dyslipidemia all increase the risk for erectile dysfunction (ED) in men with Type 2 diabetes, report researchers. However, they add that increased physical activity appears to be protective against ED in these individuals. Previous research has shown that men with diabetes have a […]

« Previous Entries